Viral Hepatitis Flashcards
Define Viral Hepatitis
Inflammation of the liver with the virus hepatitis A-E
Follows an acute course without progression to chronic carriage
Aetiology/risk factors/epidemiology/specific features of viral hepatitis A
RNA virus (single-stranded)
Trasmission via faecal-oral route (hence contaminated food)
3-6 week incubation
RF: Travelling (Africa/Asia) | Contaminated food/water
Acute presentation
Aetiology/risk factors/epidemiology/specific features of viral hepatitis B
DNA virus
Transmission: parenteral, sexual, vertical
Incubation 4-12 weeks
RF: Bodily fluids | contaminated blood e.g. IVDU | healthworkers
Most common worldwide
Acute presentation
Aetiology/risk factors/epidemiology/specific features of viral hepatitis C
RNA virus
Transmission is mainly parenteral
Incubation: 2 wks - 6 months
RF: contaminated blood
Most common in Europe
Usually asymptomatic and chronic
Aetiology/risk factors/epidemiology/specific features of viral hepatitis D
RNA virus
Transmission: Parenteral and sexual
RF: bodily fluids, contaminated blood
ONLY co-infects with Hep B
Aetiology/risk factors/epidemiology/specific features of viral hepatitis E
RNA virus
Transmission: Faecal-oral
Incubation: 3-6 weeks
RF: contaminated food/water
High mortality with pregnant women
Symptoms of Viral Hepatitis
Generic triad:
- Fever
- Jaundice
- Raised AST/ALT
Reduced appetite -> anorexia Nausea and vomiting Abdominal pain Jaundice and Pruritus Dark urine + pale stools Skin rash Joint pain
80% of hep C is asymptomatic
Signs of Viral Hepatitis on exam
Pyrexia
Jaundice
Tender hepatomegaly
Splenomegaly (20%)
Absence of CLD stigmata, may see Spider naevi
Investigations for Viral Hepatitis
Viral Serology: positive
Urinalysis: +ve for bilirubin and raised urobilinogen
LFTs: ALT/AST raised. bilirubin raised, Alk phos raised, albumin reduced
FBC: Platelets raised
ESR/CRP: raised
Nucleic acid amplification test: indicates viral load
How is viral serology for Viral hepatitis interpreted (hep B)
Early acute infection:
HbsAg +ve
Acute infection:
Anti-HBc IgM +ve
HbsAg +ve
Chronic infection:
Anti-Hbc IgG +ve
HbsAg +ve
Resolved acute HBC infection:
Anti-Hbc IgG +ve
Anti-HBs +ve
Prior vaccination
Anti-HBs +ve
Management of Viral Hepatitis
A/E - supportive care (bed rest + antipyretics + antiemetics) | cholestyramine for severe pruritus
B/C/D - supportive care (acute) | antivirals + peginterferon (chronic)
Severe: liver transplant
Immunisation for those travelling to endemic areas + high-risk individuals
Complications of Viral Hepatitis
Liver failure
Cholestatic hepatitis + prolonged jaundice
Post-hepatic syndrome: continued malaise for weeks to months
Chronic liver disease
Prognosis for Viral Hepatitis
A/E: nearly all resolve by 6 months, may have the occasional relapse, no chronic sequelae
High mortality in failure and chronic hep C